Abecassis Michael M 4
4 · PharmaCyte Biotech, Inc. · Filed Dec 12, 2025
Insider Transaction Report
Form 4
Abecassis Michael M
Director
Transactions
- Award
Common Stock
2025-12-12+37,500→ 39,167 total - Tax Payment
Common Stock
2025-12-12$1.02/sh−16,875$17,213→ 22,292 total - Award
Stock Option (Right to Buy)
2025-04-25+63,233→ 63,233 totalExercise: $1.22Exp: 2035-04-24→ Common Stock (63,233 underlying)
Holdings
- 800(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.
- [F2]The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Abecassis. This transaction is late due to an inadvertent administrative error and not any error of Mr. Abecassis.